NCT06466967View on ClinicalTrials.gov

Clinical Utility of Tight Objectives of Advanced Hybrid Closed-loop Systems Among Type 1 Diabetes Patients (TightT1AHCL)

RecruitingOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

June 15, 2024

Primary Completion Date

December 15, 2025

Study Completion Date

April 15, 2026

Conditions
Type 1 Diabetes
Interventions
DEVICE

Advanced hybrid closed-loop CamAPS FX

Treatment with a strict programmed glucose target (80-99 mg/dL).

Trial Locations (1)

13005

RECRUITING

Ciudad Real General University Hospital, Ciudad Real

All Listed Sponsors
lead

Castilla-La Mancha Health Service

OTHER